Stephen V Liu: Case report in Annals of Oncology of patients with NUT carcinoma responding to lurbinectedin

Stephen V Liu shared a post on X, about recent case report published in Annals of Oncology:

Promising Response to Lurbinectedin in NUT Carcinoma: a case report and review of emerging therapeutic strategies.

Authors: M. V. Sánchez Becerra, C. Escudero Iriarte, C. Travert, T. Tian, B. Besse.

”Case report in Annals of Oncology of patients with NUT carcinoma responding to lurbinectedin. Had transient response to first-line carboplatin, paclitaxel, pembrolizumab and started second-line lurbinectedin with rapid clinical and radiographic response (though only 4m).”

Stephen V Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer. Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.